Inventory increased 32.3%
Inventory changed +32.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory changed +32.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Net income changed -58.8% from the comparable as-filed period.
Operating income changed +131.0% from the comparable as-filed period.
Operating margin changed +2371 basis points from the comparable as-filed period.
Research & development changed +26.9% from the comparable as-filed period.
Revenue changed +52.8% from the comparable as-filed period.
Stock-based compensation changed -15.7% from the comparable as-filed period.
Cash & equivalents changed +12.3% from the comparable as-filed period.
Debt changed +8.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.